Publications

TOP > Publications

All

  • Endocrine & Cardiovascular Epidemiology

    Inoue K, Liu M, Aggarwal R, Marinacci LX, Wadhera RK. Prevalence and Control of Diabetes Among US Adults, 2013 to 2023. JAMA. 2025. Online Ahead of Print.

  • Health Services Research

    Inoue K*, Kazi DS, Vaduganathan M, Wadhera RK. Prescription Patterns for GLP-1 Receptor Agonists and SGLT2 Inhibitors by Physicians’ Years in Practice. J Gen Intern Med. 2025. Online Ahead of Print.

  • Identifying Heterogeneity

    Nianogo RA, O'Neill S, Inoue K. Generalized framework for identifying meaningful heterogenous treatment effects in observational studies: A parametric data-adaptive G-computation approach. J Stat Methods Med Res. 2025. Online Ahead of Print.

  • Identifying Heterogeneity

    Komura T, Bargagli-Stoffi FJ, Shiba K, Inoue K*. Two-Step Pragmatic Subgroup Discovery for Heterogeneous Treatment Effects Analyses: Perspectives Toward Enhanced Interpretability. Eur J Epidemiol. 2025 Online Ahead of Print.

  • Identifying Mediating Pathways Endocrine & Cardiovascular Epidemiology

    Komura T, Tsugawa Y, Yabe D, Kondo N, Inoue K*. Depression Risk Associated with Spouses’ Diabetes and Cardiovascular Events: A Nationwide Cohort Study. Am J Epidemiol. 2025 Online Ahead of Print.

  • Identifying Heterogeneity

    Athey S, Inoue K, Tsugawa Y. Targeted Treatment Assignment Using Data from Randomized Experiments with Noncompliance. AEA Papers and Proceedings. 2025, 115: 1–6.

  • Identifying Heterogeneity Health Services Research

    Inoue K*, Athey S, Baicker K, Tsugawa Y. Heterogeneous effects of Medicaid coverage on cardiovascular risk factors: secondary analysis of randomized controlled trial. BMJ. 2024; 386: e079377.

  • Endocrine & Cardiovascular Epidemiology

    Yagi R, Mori Y, Goto S, Iwami T, Inoue K*. Routine Electrocardiogram Screening and Cardiovascular Disease Events in Adults. JAMA Internal Medicine. 2024; 184(9):1035-1044.

  • Endocrine & Cardiovascular Epidemiology

    Mori Y, Komura T, Adomi M, Yagi R, Fukuma S, Kondo N, Yanagita M, Duru OK, Tuttle KR, Inoue K*. Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Events Among Patients with Type 2 Diabetes and Low-to-Normal Body Mass Index: A Nationwide Cohort Study with Target Trial Emulation. Cardiovascular Diabetology. 2024;23(1):372.

  • Identifying Heterogeneity

    Inoue K*, Adomi M, Efthimiou O, Komura T, Omae K, Onishi A, Tsutsumi Y, Fujii T, Kondo N, Furukawa AT. Machine Learning Approaches to Evaluate Heterogeneous Treatment Effects in Randomized Controlled Trials: A Scoping Review. J Clin Epidemiol. 2024; 176: e111538.

  • Endocrine & Cardiovascular Epidemiology

    Komura T, Tsugawa Y, Mayeda ER, Glymour MM, Inoue K*. Association of Cardiovascular Events with Spouse’s Subsequent Dementia. JAMA Neurology. 2024: 81(10): 1098-1099.

  • Identifying Heterogeneity

    Naito T, Inoue K (co-first), Namba S, Sonehara K, Suzuki K, BioBank Japan, Yamamoto K, Baba R, Kodama T, Otagaki Y, Okada A, Itcho K, Kobuke K, Ohno H, Biobank Japan, Matsuda K, Kondo N, Toda T, Yamauchi T, Kadowaki T, Okada Y. A machine learning approach reveals heterogeneous association of environmental factors with diseases across polygenic risk scores: an application to cardiovascular diseases and type 2 diabetes. Communications Medicine. 2024; 4(1): 181.

  • Inoue K*, Sakamaki K, Komukai S, Ito Y, Goto A, Shinozaki T. Confounder Selection and Sensitivity Analyses to Unmeasured Confounding from Epidemiological and Statistical Perspectives. Journal of Epidemiology. 2024; 35(1): 3-10.

  • Endocrine & Cardiovascular Epidemiology

    Inoue K*, Naito T, Fujii R, Sonehara K, Yamamoto K, Baba R, Kodama T, Otagaki Y, Okada A, Itcho K, Kobuke K, Ohno H, BioBank Japan, Morisaki T, Hattori N, Goto A, Nishikawa T, Oki K, Okada Y. Primary aldosteronism and risk of cardiovascular outcomes: Genome-wide association and Mendelian randomization study. J. Am. Heart Assoc. 2024; 13(15): e034180.

  • Endocrine & Cardiovascular Epidemiology

    Sohn SY, Inoue K, Rhee CM, Leung AM. Risks of Iodine Excess. Endocrine Reviews. 2024; 45(7): 858-879.

  • Endocrine & Cardiovascular Epidemiology

    Komura T, Tsugawa Y, Kondo N, Inoue K*. Depression Onset After a Spouse’s Cardiovascular Event: A Nationwide Analysis in Japan. JAMA Network Open. 2024;7(4): e244602.

  • Identifying Heterogeneity

    Shiba K, Inoue K*. Harnessing Causal Forests for Epidemiologic Research: Key Consideration. Am J Epidemiol. 2024:kwae003.

  • Identifying Heterogeneity

    Inoue K*, Athey S, Tsugawa Y. Machine-learning-based high-benefit approach versus conventional high-risk approach in blood pressure management. International Journal of Epidemiology. 2023;52(4):1243-1256

  • Identifying Mediating Pathways

    Inoue K*, Seeman T, Nianogo R, Okubo Y. The Effect of Poverty on the Relationship between Household Education Levels and Obesity in U.S. Children and Adolescents: An Observational Study. The Lancet Regional Health - Americas. 2023;25:100565.

  • Endocrine & Cardiovascular Epidemiology

    Inoue K, Guo R, Lee M, Neverova N, Ebrahimi R, Currier J, Bashir M, Leung AM. Iodine-Induced Hypothyroidism and Long-term Risks of Incident Heart Failure. Journal of American Heart Association. 2023;12(20):e030511.

  • Endocrine & Cardiovascular Epidemiology

    Inoue K, Guo R, Lee M, Ebrahimi R, Neverova N, Currier J, Bashir M, Leung AM. Iodine-Induced Hyperthyroidism and Long-term Risks of Incident Atrial Fibrillation and Flutter. J Clin Endocrinol Metab. 2023;108(10):e956-e962.

  • Endocrine & Cardiovascular Epidemiology

    Inoue K*, Tsugawa Y, Mayeda ER, Ritz B. Association of Daily Step Patterns with Mortality in US adults. JAMA Network Open. 2023;6(3):e235174.

  • Identifying Mediating Pathways

    Goto R, Kawachi I, Kondo N, Inoue K. Contribution of Vaccinations to Reducing Socioeconomic Disparities in COVID-19 Deaths Across US counties. Annals of Epidemiology. 2023;86:65-71.e3.

  • Endocrine & Cardiovascular Epidemiology

    Naito T, Inoue K, Sonehara K, Baba R, Kodama T, Otagaki Y, Okada A, Itcho K, Kobuke K, Kishimoto S, Yamamoto K, BioBank Japan, Morisaki T, Higashi Y, Hinata N, Arihiro K, Hattori N, Okada Y, Oki K. Genetic risk of primary aldosteronism and its contribution to hypertension: a cross-ancestry meta-analysis of genome-wide association study. Circulation. 2023;147(14):1097-1109.

  • Endocrine & Cardiovascular Epidemiology

    Sato K, Noguchi H, Inoue K, Kawachi I, Kondo N. Retirement and cardiovascular disease: A longitudinal study in 35 countries. Int J Epidemiology. 2023;52(4):1047-1059.

  • Identifying Heterogeneity

    Goto R, Inoue K, Osawa I, Baicker K, Fleming S, Tsugawa Y. Machine learning detects heterogeneous effects of Medicaid coverage on depression. American Journal of Epidemiology. 2023;kwae008.

  • Identifying Heterogeneity Endocrine & Cardiovascular Epidemiology

    Inoue K*, Seeman T, Horwich T, Budoff M, Watson KE. Heterogeneity in the Association Between the Presence of Coronary Artery Calcium and Cardiovascular Events: A Machine Learning Approach in the MESA Study. Circulation. 2022;147(2):132-141.

  • Endocrine & Cardiovascular Epidemiology

    Inoue K, Rong G, Lee ML, Ebrahimi R, Neverova N, Currier J, Bashir M, Leung AM. Iodinated Contrast Administration and Risks of Thyroid Dysfunction: A Retrospective Cohort Analysis of the U.S. Veterans Health Administration System. Thyroid. 2022;33(2):230-238.

  • Endocrine & Cardiovascular Epidemiology

    Mori Y, Duru OK, Tuttle K, Fukuma S, Taura D, Harada N, Inagaki N, Inoue K*. Sodium-Glucose Cotransporter 2 Inhibitors and New-onset Type 2 Diabetes in Adults with Prediabetes: systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Endocrinology and Metabolism. 2022;108(1):221-231.

  • Health Services Research

    Inoue K*, Figueroa F, Kondo N, Tsugawa Y. Changes in Industry Marketing Payments to Physicians during the COVID-19 pandemic: Quasi-experimental Difference-in-difference Study. BMJ Medicine. 2022;1(1):e000219.

  • Identifying Mediating Pathways

    Inoue K*, Ritz B, Arah OA. Causal Effect of Chronic Pain on Mortality through Opioid prescriptions: An Application of the Front-Door Formula. Epidemiology. 2022;33(4):572-580.

  • Endocrine & Cardiovascular Epidemiology

    Inoue K*, Horwich T, Bhatnagar R, Bhatt K, Goldwater D, Seeman T, Watson KE. Urinary stress hormones, hypertension, and cardiovascular events: the Multi-Ethnic Study of Atherosclerosis. Hypertension. 2021;78(5):1640-1647.

  • Health Services Research

    Inoue K*, Tsugawa Y, Mangione CM, Duru OK. Association Between Industry Payments and Prescriptions of Long-acting Insulin: An Observational Study with Propensity-Score Matching. PLOS Medicine. 2021;18(6): e1003645.

  • Health Services Research

    Inoue K, Figueroa JF, DeJong CD, Tsugawa Y, Orav EJ, Shen C, Kazi DS. Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States. Circulation: Cardiovascular Quality and Outcomes. 2021;14(5):e007521.

  • Identifying Heterogeneity

    Inoue K, Hsu W, Arah OA, Prosper A, Aberle D, Bui A. Generalizability and transportability of the results from randomized controlled trials: An example using the National Lung Screening Trial. Cancer Epidemiology, Biomarkers & Prevention. 2021;30(12):2227-2234.

  • Endocrine & Cardiovascular Epidemiology

    Inoue K*, Nianogo R, Telesca D, Goto A, Khachadourian V, Tsugawa Y, Sugiyama T, Mayeda ER, Ritz B. Low HbA1c levels and all-cause or cardiovascular mortality among people without diabetes: the US National Health and Nutrition Examination Survey 1999-2015. International Journal of Epidemiology. 2020;50(4):1373-1383.

  • Identifying Mediating Pathways

    Inoue K, Mayeda ER, Paul K, Haan MN, Ritz B. Mediation of the Associations of Physical Activity With Cardiovascular Events and Mortality by Diabetes in Older Mexican Americans. American Journal of Epidemiology. 2020;189(10):1124-1133.

  • Identifying Mediating Pathways Endocrine & Cardiovascular Epidemiology

    Inoue K*, Goldwater D, Allison M, Seeman T, Watson K. Serum Aldosterone Concentration, Coronary Artery Calcium, and Mortality: The Multi-Ethnic Study of Atherosclerosis. Hypertension. 2020;76(1):113-120. - Selected as a High-impact paper for Fall 2020 -

  • Endocrine & Cardiovascular Epidemiology

    Inoue K*, Ritz B, Ebrahimi R, Rhee C, Brent GA, Leung AM. Association of Subclinical Hypothyroidism and Cardiovascular Disease With Mortality. JAMA Network Open. 2020;3(2):e1920745.

  • Identifying Mediating Pathways

    Inoue K, Yan Q, Arah OA, Paul K, Walker DI, Jones DP, Ritz B. Air pollution and adverse birth outcomes: Mediation analysis using metabolomic profiles. Current Environmental Health Reports. 2020;7(3):231-242

  • Endocrine & Cardiovascular Epidemiology

    Inoue K*, Ritz B, Andersen SL, Ramlau-Hansen CH, Høyer BB, Bech BH, Henriksen TB, Bonefeld-Jørgensen EC, Olsen J, Liew Z. Perfluoroalkyl Substances and maternal thyroid hormones in early pregnancy; findings in the Danish National Birth Cohort. Environmental Health Perspectives. 2019;127(11):117002.

  • Health Services Research

    Inoue K*, Blumenthal DM, Elashoff D, Tsugawa Y. Association between physician characteristics and payments from industry in 2015–2017: observational study. BMJ Open. 2019;9(9):e031010.

  • Endocrine & Cardiovascular Epidemiology

    Inoue K, Yamazaki Y, Kitamoto T, Hirose R, Saito J, Omura M, Sasano H, Nishikawa T. Aldosterone Suppression by Dexamethasone in Patients with Aldosterone-producing Adenoma Harboring Somatic KCNJ5 Mutations. Journal of Clinical Endocrinology and Metabolism. 2018;103(9):3477-3485.

  • Endocrine & Cardiovascular Epidemiology

    Inoue K*, Leung AM, Sugiyama T, Tsujimoto T, Makita N, Nangaku M, Ritz B. Urinary Iodine Concentrations and Mortality Among U.S. Adults. Thyroid. 2018;28(7):913-920.

  • Endocrine & Cardiovascular Epidemiology

    Inoue K*, Tsujimoto T, Saito J, Sugiyama T. Association between serum thyrotropin levels and mortality among euthyroid adults in the United States. Thyroid. 2016;26(10):1457-1465.